Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. NASDAQ OMX GlobeNewswire Message Board

BioLargo receives OCTANe 2017 High Tech Innovation

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 301275
(Total Views: 29)
Posted On: 10/16/2017 12:00:23 PM
Avatar
Posted By: News Desk 2018
BioLargo receives OCTANe 2017 High Tech Innovation Award

Westminster, CA , Oct. 16, 2017 (GLOBE NEWSWIRE) --  -- BioLargo, Inc. (OTCQB:BLGO), a sustainable science, technology and full-service environmental engineering company that makes life better by delivering world-class products and services across a broad range of industries, with a drive to deliver clean water, clean air and advanced wound care, announced today that it had received a High Tech Innovation award as the “Best Horizontal Disruption” company at   OCTANe ’s (www.octaneoc.org) 24 th annual award ceremony, held at the Balboa Bay Resort on October 12, 2017.  OCTANe is Orange County's leading technology and life sciences small business accelerator organization. This awards program ( www.octanehta.com ) honors Orange County-based companies who have demonstrated exceptional leadership in developing new technological advancements in their respective industries.

Awards were given to recognize outstanding innovators in categories including software, digital strategy, device and hardware, healthcare, medical technology, digital communications, intelligent data analytics, horizontal disruption, intrapreneurship and corporate culture. Nearly 100 prestigious companies in the Orange County area were nominated for an award this year and from that group, 30 were named as finalists. The winners were then selected by a panel of 12 independent judges.

The 2017 finalists were:

  • 11 Health
  • Allegro Ophthalmics
  • Alteryx
  • Arbitech
  • BioLargo
  • BioPhotas
  • BirchStreet
  • Cie Digital Labs
  • Compellon
  • D-Link
  • Enevate
  • EnteroMedics, Inc.
  • GeoCommerce
  • Glaukos
  • GlobeChat
  • Harbor MedTech
  • HyperX
  • Immunant
  • loanDepot
  • MeU CARE
  • NarrativeWave
  • NCompassTrac
  • RapidScale
  • Sonendo
  • Swift Engineering
  • Syspro
  • Veracity
  • Velox Biosystems
  • Vertos Medical
  • Xitore

The OCTANe High Tech Innovation Awards were sponsored by BNY Mellon, Deloitte, Grant Thornton, Haskell & White, RSM, Savills Studley, Stradling, Squar Milner, TriNet, UPS and Woodruff Sawyer.

President & CEO of BioLargo, Dennis P. Calvert commented, “This very important milestone recognizing our team, our technology and our continuing mission to make life better. We are proud to receive this prestigious recognition from OCTANe.”

About BioLargo, Inc.

BioLargo, Inc. is a sustainable science, technology and full-service environmental engineering company that makes life better by delivering world-class products and services across a broad range of industries, with a drive to deliver clean water, clean air and advanced wound care. More information can be found about the company at  www.BioLargo.com . Its engineering division ( www.BioLargoEngineering.com ) features an exceptional team of experienced specialists dedicated to integrity, reliability, safety, and environmental stewardship. It water division ( www.BioLargoWater.com ) showcases its emerging technology, the Advanced Oxidation System “AOS”, an award-winning product, having been awarded more than 35 research grants and counting, specifically designed to eliminate common, troublesome, and dangerous contaminants in water in a fraction of the time and cost of current technologies. Its odor division features sustainable odor elimination products including its CupriDyne Clean ( www.CupriDyne.com ) Industrial Odor Eliminator, a product currently serving the leading solid waste handling and wastewater treatment companies as well as any industry that that contends with malodors, VOC’s or similar air quality related problems. Its personal care product division features products in the pet, equine, military supply and consumer markets, and include the Nature's Best Solution® and Deodorall® brands ( www.OdorNoMore.com ). Its medical division ( www.ClyraMedical.com ) focuses on advanced wound care management, featuring effective and gentle solutions for chronic infected wounds and other uses to promote infection control and regenerative tissue therapy. BioLargo also owns a 50% interest in the Isan System, a fully automated iodine dosing system being commercialized under a license to Clarion Water, Inc (www.ClarionWater.com).

About OCTANe  OCTANe drives innovation and growth by connecting people, resources and capital to fuel technology growth in Southern California. Its members represent technology executive leaders, entrepreneurs, investors, venture capitalists, academicians, and strategic advisors, all working together to fuel innovation in the OC. The organization has helped more than 800 companies via the LaunchPad™ SBDC accelerator. LaunchPad™ companies have received more than $2.1 billion in investment and equity exits. OCTANe annually welcomes more than 7,000 people to its programs and events. More than 2,000 business leaders throughout the region are OCTANe members. For more information, visit  www.octaneoc.org .

Safe Harbor Statement The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo's current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo's Annual Report on Form 10-K.

Company Contact Dennis Calvert President and CEO BioLargo, Inc. 949-643-9540 x2



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us